Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Moheimani HR"'
Autor:
Enayati A; Ischemic Disorders Research Center, Golestan University of Medical Sciences, P.O.BOX. 4934174515, Gorgan, Iran. enayati_phyto@yahoo.com., Salehi A; Ischemic Disorders Research Center, Golestan University of Medical Sciences, P.O.BOX. 4934174515, Gorgan, Iran., Alilou M; Institute of Pharmacy/Pharmacognosy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80/82, 6020, Innsbruck, Austria., Stuppner H; Institute of Pharmacy/Pharmacognosy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80/82, 6020, Innsbruck, Austria., Polshekan M; Ischemic Disorders Research Center, Golestan University of Medical Sciences, P.O.BOX. 4934174515, Gorgan, Iran., Rajaei M; Ischemic Disorders Research Center, Golestan University of Medical Sciences, P.O.BOX. 4934174515, Gorgan, Iran., Pourabouk M; Ischemic Disorders Research Center, Golestan University of Medical Sciences, P.O.BOX. 4934174515, Gorgan, Iran., Jabbari A; Ischemic Disorders Research Center, Golestan University of Medical Sciences, P.O.BOX. 4934174515, Gorgan, Iran.; Research Clinical Development unit (CRDU) 5 Azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran., Mazaheri Z; Ischemic Disorders Research Center, Golestan University of Medical Sciences, P.O.BOX. 4934174515, Gorgan, Iran., Yassa N; Department of Pharmacognosy, Faculty of Pharmacy and Medicinal Plants Research Center, Tehran University of Medical Sciences, Tehran, Iran., Moheimani HR; Ischemic Disorders Research Center, Golestan University of Medical Sciences, P.O.BOX. 4934174515, Gorgan, Iran., Khori V; Ischemic Disorders Research Center, Golestan University of Medical Sciences, P.O.BOX. 4934174515, Gorgan, Iran. vahid.khori@yahoo.com.
Publikováno v:
BMC complementary medicine and therapies [BMC Complement Med Ther] 2021 Nov 26; Vol. 21 (1), pp. 288. Date of Electronic Publication: 2021 Nov 26.
Autor:
Moheimani HR; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Amiriani T; Golestan Research Center of Gastroenterology and Hepatology, Gorgan, Iran., Alizadeh AM; Cancer Research Center of Institute Cancer, Tehran University of Medical Science, Tehran, Iran., Jand Y; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran; Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Shakiba D; Department of Mechanical Engineering and Material Science, Washington University in St. Louis, St. Louis, MO, USA., Ensan PS; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Jafarzadeh F; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Rajaei M; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Enayati A; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Pourabouk M; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Aliazadeh S; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Pourkhani AH; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Mazaheri Z; Basic Medical Science Research Center, Histogenotech Company, Tehran, Iran., Zeyghami MA; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Dehpour A; Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: dehpoura@sina.tums.ac.ir., Khori V; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran. Electronic address: vahid.khori@yahoo.com.
Publikováno v:
European journal of pharmacology [Eur J Pharmacol] 2021 Feb 15; Vol. 893, pp. 173807. Date of Electronic Publication: 2021 Jan 05.
Autor:
Khori V; Ischemic Disorders Research Center, Golestan University of Medical Sciences, 49175553, Gorgan, Iran., Alizadeh AM, Moheimani HR, Zahedi M, Aminolsharieh Najafi S, Shakiba D, Nayebpour M
Publikováno v:
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2015 Feb; Vol. 29 (1), pp. 41-53. Date of Electronic Publication: 2014 Oct 02.
Autor:
Khori V; Golestan Cardiovascular research center, Golestan University of Medical Sciences, Gorgan, Iran., Najafi SA, Alizadeh AM, Moheimani HR, Shakiba D, Alizadeh F, Nayebpour M
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2012 Jul; Vol. 385 (7), pp. 697-706. Date of Electronic Publication: 2012 Apr 28.